RTI Surgical (RTIX) Receiving Positive News Coverage, Study Finds

Headlines about RTI Surgical (NASDAQ:RTIX) have been trending positive recently, Accern reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. RTI Surgical earned a news sentiment score of 0.26 on Accern’s scale. Accern also gave press coverage about the medical equipment provider an impact score of 45.9708454591368 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

RTIX traded up $0.05 during trading on Thursday, reaching $4.60. 64,881 shares of the company’s stock were exchanged, compared to its average volume of 122,261. RTI Surgical has a one year low of $3.85 and a one year high of $5.10. The company has a debt-to-equity ratio of 0.30, a current ratio of 3.86 and a quick ratio of 1.55. The firm has a market capitalization of $285.20 million, a price-to-earnings ratio of 92.00, a PEG ratio of 2.73 and a beta of 1.56.

RTI Surgical (NASDAQ:RTIX) last issued its quarterly earnings results on Thursday, August 2nd. The medical equipment provider reported $0.03 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.01 by $0.02. The firm had revenue of $70.69 million for the quarter, compared to the consensus estimate of $70.09 million. RTI Surgical had a net margin of 1.23% and a return on equity of 3.04%. equities research analysts predict that RTI Surgical will post 0.11 EPS for the current year.

A number of equities research analysts have weighed in on the stock. ValuEngine raised shares of RTI Surgical from a “hold” rating to a “buy” rating in a report on Monday, July 2nd. Zacks Investment Research raised shares of RTI Surgical from a “hold” rating to a “buy” rating and set a $5.25 target price on the stock in a report on Tuesday, August 7th. Finally, BidaskClub raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a report on Tuesday, July 3rd.

RTI Surgical Company Profile

RTI Surgical, Inc, together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.

Recommended Story: Relative Strength Index

Insider Buying and Selling by Quarter for RTI Surgical (NASDAQ:RTIX)

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply